Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Amniotics

 

Amniotics logo

 

Researchers Marcus Larsson, Andreas Herbst and Niels-Bjarne Woods have discovered new stem cells in amniotic fluid, which have unique characteristics for applications in regenerative medicine. Using a completely new method, these new stem cells can be collected and processed before being utilised in medical applications.

Cells from the amniotic fluid are unexploited resources that have been shown to be favorable for reprogramming to several other target tissues. These primitive cells are collected from a very oxygen-poor environment, which gives the cells good properties. Using this new technology retains the low oxygen level during collection and processing.

Amniotics website

 

 

 

Amniotics

New unique stem cells in amniotic fluid that are very suitable for medical applications.

Founded by Marcus Larsson, Andreas Herbst and Niels-Bjarne Woods.

Portfolio company since 2015.

 

Portfolio Manager LU Holding:

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78